EP0662782A4 - Pp14-basierte therapie. - Google Patents

Pp14-basierte therapie.

Info

Publication number
EP0662782A4
EP0662782A4 EP93922763A EP93922763A EP0662782A4 EP 0662782 A4 EP0662782 A4 EP 0662782A4 EP 93922763 A EP93922763 A EP 93922763A EP 93922763 A EP93922763 A EP 93922763A EP 0662782 A4 EP0662782 A4 EP 0662782A4
Authority
EP
European Patent Office
Prior art keywords
based therapy
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93922763A
Other languages
English (en)
French (fr)
Other versions
EP0662782A1 (de
Inventor
Mark L Tykocinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0662782A1 publication Critical patent/EP0662782A1/de
Publication of EP0662782A4 publication Critical patent/EP0662782A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation
EP93922763A 1992-09-30 1993-09-28 Pp14-basierte therapie. Withdrawn EP0662782A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95480292A 1992-09-30 1992-09-30
US954802 1992-09-30
PCT/US1993/009216 WO1994007366A1 (en) 1992-09-30 1993-09-28 Pp14-based therapy

Publications (2)

Publication Number Publication Date
EP0662782A1 EP0662782A1 (de) 1995-07-19
EP0662782A4 true EP0662782A4 (de) 1995-10-25

Family

ID=25495948

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93922763A Withdrawn EP0662782A4 (de) 1992-09-30 1993-09-28 Pp14-basierte therapie.

Country Status (5)

Country Link
EP (1) EP0662782A4 (de)
JP (1) JPH08502257A (de)
AU (1) AU5165993A (de)
CA (1) CA2145762A1 (de)
WO (1) WO1994007366A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111743A0 (en) * 1993-12-08 1995-01-24 Intermune Life Sciences Inc Recombinant genes expressing pp14
IL150572A0 (en) * 2000-01-03 2003-02-12 Tr Associates L L C Pp14 fusion proteins and methods for making and using the same
WO2004093907A2 (en) * 2003-04-23 2004-11-04 Tomoaki Hoshino Therapeutic agents for treating dermatitis, alopecia and itching and transgenic animals for evaluating such therapeutic agents

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0378418A2 (de) * 1989-01-11 1990-07-18 Intermune Life Sciences, Inc. Proliferationsinhibitoren von Immunzellen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0378418A2 (de) * 1989-01-11 1990-07-18 Intermune Life Sciences, Inc. Proliferationsinhibitoren von Immunzellen

Also Published As

Publication number Publication date
CA2145762A1 (en) 1994-04-14
JPH08502257A (ja) 1996-03-12
WO1994007366A1 (en) 1994-04-14
EP0662782A1 (de) 1995-07-19
AU5165993A (en) 1994-04-26

Similar Documents

Publication Publication Date Title
EP0597463A3 (en) Thermotherapiesonde.
EP0580285A3 (de) Selbsttätige Wiedereinschalter.
GR3025363T3 (en) Medicaments.
GR3022484T3 (en) Osteosynthesis aid.
EP0666752A4 (de) Therapeutische mikroemulsionen.
EP0572808A3 (de) Antiblockierregelsystem.
EP0668864A4 (de) Substituierte biphenylmethylimidazopyridine.
GB9203039D0 (en) Treatment
EP0599191A3 (de) Motordrehzahlregler-Schaltkreis.
EP0592354A3 (de) Vakuum-Zentrifuge.
PH31659A (en) Therapeutic nucleotides.
EP0663819A4 (de) Ibuprofen-coffein-kombinationen.
ZA946217B (en) Therapeutic combination
EP0662782A4 (de) Pp14-basierte therapie.
EP0624089A4 (en) Methods.
ZA935828B (en) New insobutyl-substituted methanesulphonyl-quinolyl-methoxyphenyl-cycloalkylacetamides.
ZA929916B (en) Therapeutic agents.
ZA931403B (en) Sulphonamidocarboxamides.
GB9323437D0 (en) Therapy
EG19223A (en) Therapeutic agents.
ZA933136B (en) Therapeutic alcohols.
ZA928102B (en) Therapeutic agent.
ZA939705B (en) Inhalter devices.
GB9210270D0 (en) Therapeutic combinations
GB9216088D0 (en) Therapeutic combinations

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950428

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19950912

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RHK1 Main classification (correction)

Ipc: C12N 15/10

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19980401